Incidental adnexal masses detected at low-dose unenhanced CT in asymptomatic women age 50 and older: Implications for clinical management and ovarian cancer screening

Radiology

Volumn 257, Issue 1, 2010, Pages 144-150

  Pickhardt, Perry J ^a   Hanson, Meghan E ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BRENNER TUMOR; CANCER SCREENING; COHORT ANALYSIS; COLON RADIOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; CYSTADENOMA; DIAGNOSTIC IMAGING; ENDOMETRIUM TUMOR; FEMALE; FEMALE GENITAL TRACT TUMOR; HISTOPATHOLOGY; HUMAN; HYDROSALPINX; INCIDENTAL FINDING; LOW ENERGY RADIATION; MAJOR CLINICAL STUDY; OVARY CANCER; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; TERATOMA; TRANSVAGINAL ECHOGRAPHY;

ADNEXAL DISEASES; AGED; AGED, 80 AND OVER; CA-125 ANTIGEN; COLONOGRAPHY, COMPUTED TOMOGRAPHIC; FEMALE; HUMANS; INCIDENTAL FINDINGS; MASS SCREENING; MIDDLE AGED; OVARIAN NEOPLASMS; POSTMENOPAUSE; PREVALENCE; TOMOGRAPHY, X-RAY COMPUTED; TUMOR MARKERS, BIOLOGICAL;

EID: 77957375739     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.10100511     Document Type: Article

References (23)

1. Jemal A, Siegel R, Ward E, Hao YP, Xu JQ, Thun MJ. Cancer statistics, 2009. CA Cancer J Clin 2009;59(4):225-249.
2. Javitt MC. Risk assessment for ovarian carcinoma: hope or hype? AJR Am J Roentgenol 2010;194(2):308.
3. Miller JC, Horowitz NS, Thrall JH, Lee SI. Evaluating adnexal lesions: which need follow-up? J Am Coll Radiol 2007;4(10): 725-729.
4. McDonald JM, Modesitt SC. The incidental postmenopausal adnexal mass. Clin Obstet Gynecol 2006;49(3):506-516.
5. Bailey CL, Ueland FR, Land GL, et al. The malignant potential of small cystic ovarian tumors in women over 50 years of age. Gynecol Oncol 1998;69(1):3-7.
6. Fishman DA, Cohen L, Blank SV, et al. The role of ultrasound evaluation in the detection of early-stage epithelial ovarian cancer. Am J Obstet Gynecol 2005;192(4): 1214-1221.
7. Pickhardt PJ, Taylor AJ. Extracolonic findings identified in asymptomatic adults at screening CT colonography. AJR Am J Roentgenol 2006;186(3):718-728.
8. Kim DH, Pickhardt PJ, Taylor AJ, et al. CT colonography versus colonoscopy for the detection of advanced neoplasia. N Engl J Med 2007;357(14):1403-1412. (Pubitemid 47535594)
9. Pickhardt PJ, Hanson ME, Vanness DJ, et al. Unsuspected extracolonic findings at screening CT colonography: clinical and economic impact. Radiology 2008;249(1): 151-159.
10. Zalis ME, Barish MA, Choi JR, et al. CT colonography reporting and data system: a consensus proposal. Radiology 2005; 236(1):3-9.
11. Iyer VR, Lee SI. MRI, CT, and PET/CT for ovarian cancer detection and adnexal lesion characterization. AJR Am J Roentgenol 2010; 194(2):311-321.
12. Stitt IA, Stany MP, Moser RP 3rd, Rose GS, Dunlow SG. Incidental gynecological findings on computed tomographic colonography: prevalence and outcomes. Gynecol Oncol 2009;115(1):138-141.
13. van Nagell JR, DePriest PD. Management of adnexal masses in postmenopausal women. Am J Obstet Gynecol 2005;193(1):30-35. (Pubitemid 40991823)
14. Pickhardt PJ, Kim DH, Meiners RJ, et al. Colorectal and extracolonic cancers detected at screening CT colonography in 10,286 asymptomatic adults. Radiology 2010;255(1): 83-88.
15. Stany MP, Maxwell GL, Rose GS. Clinical decision making using ovarian cancer risk assessment. AJR Am J Roentgenol 2010; 194(2):337-342.
16. Gulden C, Olopade OI. Risk assessment and genetic testing for ovarian cancer. AJR Am J Roentgenol 2010;194(2):309-310.
17. ACOG Committee on Gynecologic Practice. The role of the generalist obstetrician-gynecologist in the early detection of ovarian cancer. Gynecol Oncol 2002;87(3):237-239.
18. American College of Obstetricians and Gynecologists; ACOG Committee on Practice Bulletins-Gynecology; ACOG Committee on Genetics; Society of Gynecologic Oncologists. ACOG Practice Bulletin No. 103: hereditary breast and ovarian cancer syndrome. Obstet Gynecol 2009;113(4):957-966.
19. Dutta S, Wang FQ, Fleischer AC, Fishman DA. New frontiers for ovarian cancer risk evaluation: proteomics and contrast-enhanced ultrasound. AJR Am J Roentgenol 2010; 194(2):349-354.
20. Bast RC Jr, Badgwell D, Lu Z, et al. New tumor markers: CA125 and beyond. Int J Gynecol Cancer 2005;15(suppl 3):274-281. (Pubitemid 43096594)
21. Moore RG, MacLaughlan S, Bast RC Jr. Current state of biomarker development for clinical application in epithelial ovarian cancer. Gynecol Oncol 2010;116(2): 240-245.
22. Jacobs I, Bast RC Jr. The CA 125 tumour-associated antigen: a review of the literature. Hum Reprod 1989;4(1):1-12. (Pubitemid 19069900)
23. Moore RG, McMeekin DS, Brown AK, et al. A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass. Gynecol Oncol 2009;112(1):40-46.